United States · 
How much has Tvardi Therapeutics raised?
Tvardi Therapeutics has raised $81M across 2 rounds since 2018.
201920202021
$9.0MSeries A$72MSeries B
United States · Series B startup
Who invested in Tvardi Therapeutics
2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Tvardi Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$81Mraised across 2 rounds since 2018, from 2 sources
$9.0MSeries A$72MSeries B
- Latest round
- Series B, $72MJun 2021
- Step-upi
- 8×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $9.0M Sept 2018
- Biggest round
- $72M Series B · Jun 2021
- Between rounds
- 2.7 years from the last two
The rounds
- Jun 2021Series B$72M
No investor was named in the report.
Source recordedSEC filing: $72M sold, first sale Jun 2021
- Sept 2018Series A$9.0M
No investor was named in the report.
Reported by PehubSEC filing: $5.6M sold, first sale Jun 2018
Funding filed with regulators
Tvardi Therapeutics filed 2 raises, $78M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jun 2021$72MSEC Form D
- Jun 2018$5.6MSEC Form D
Founders and team
From the SEC filings it signed: 1 on the team.
- Imran AlibhaiExecutive Officer, Directori
On the board, as filediJamie McNabMichael WyzgaSujal ShahWallace Hall
Also claim to have backed them
This firm lists Tvardi Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Tvardi Therapeutics
When did Tvardi Therapeutics last raise?
Tvardi Therapeutics's most recent round was a Series B of $72M in Jun 2021.
What was Tvardi Therapeutics's biggest round?
Its most recent round, $72M in Jun 2021, is also its largest on record.
What stage is Tvardi Therapeutics at?
Tvardi Therapeutics's latest named round is a Series B, in Jun 2021.
Where is Tvardi Therapeutics based?
Tvardi Therapeutics is based in the United States.
Companies like Tvardi Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.